NCT06876402View on ClinicalTrials.gov

Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)

Active, not recruitingOBSERVATIONAL

Enrollment

367

Participants

Timeline

Start Date

September 9, 2013

Primary Completion Date

October 13, 2024

Study Completion Date

May 15, 2025

Conditions

NSCLC (Non-small Cell Lung Cancer)

Trial Locations (1)

11526

Hellenic Cooperative Oncology Group (HeCOG), Athens

All Listed Sponsors

lead

Hellenic Cooperative Oncology Group

OTHER